inotropes / vasopressors:
	- dopamine
	- dobutamine
		- beta agonist -> increase cAMP -> increases contractility
		- arrhythmogenic
		- increased risk of sudden death w/ HF

	- milrinone
		- PDE3 inhibitor -> increase cAMP -> increases contractility
		- arrhythmogenic
		- increased risk of sudden death w/ HF

	- digoxin
		- inhibits Na-K ATPase pump in cardiac myocytes
			- increased Na -> increased Ca exchange -> increased contractility
		- side effects:
			- nausea
			- vomiting
			- "seeing yellow"
			- arrhythmias
				- PVCs
				- accelerated junction rhythm
				- heart block


RAAS inhibitors
	- side effects:
		- hypotension
		- renal insuffenciency (dilation of efferent arterioles)
		- hyperkalemia (decreased aldosterone formation)
		- angiodema (allergy)

	- ACE inhibitors
		- reduce afterload
		- increase renal blood flow
		- decrease adrenergic tone
		- reverse myocardial fibrosis
		- specific side effects: cough (decreased bradykinin breakdown)
		- list:
			- captopril
			- enalapril
			- lisinopril
		
	- ARB inhibitors
		- less drug withdrawals than ACEi
		- list:
			- candesartan cilexetil
			- losartan
			- valsartan


vasodilators:
	- venodilators:
		- nitrates:
			- for angina pectoris (decreases O2 demand), acute coronary syndromes, HF
			- causes venous pooling, decreased right + left filling
			- SVR unaffected
			- CO may decrease due to decreased preload
			- high doses -> arteriolar dilation -> treat CAD / coronary artery spasms
			- lingual for acute angina
			- iv for unstable angina, pulmonary edema, HF
			- builds tolerance
			- side effects:
				- htx
				- reflex tachycardia
				- headache
				- flushing

		- sildenafil (viagra):
			- pulmonary vasodilator
			- cannot be used with nitrates
				- causes severe systemic hypotx

		- isosorbide:
			- used with hydralazine for systolic heart failure

	- mixed:
		- nitroprusside:
			- very potent, rapid
			- decreased CO in normal LV
			- increased CO in reduced LV function (due to decreased SVR)
			- increased venous capacitance
			- only used with elevated SVR
			- for htx emergency and severe CHF
			- onset at 30s, peak at 2 mins
			- side effects:
				- thiocyanate toxicity (cyanide poisoning)
					- blurred vision
					- tinnitus
					- disorientation
					- nausea
		- nitroglycerin (mainly venodilation):
			- decreases SVR
			- increases venous capacitance
			- can cause hypotension
			- tachyphylaxis

		- ACE inhibitors / ARBs
		- α-adrenergic blockers
		- α2-central agonists
		- nesiritide

	- arteriolar dilators
		- hydralazine
			- potent, direct
			- used when high creatinine (renal failure, avoid ACEi + ARB)
			- half life 2-4 hours
			- slow and fast metabolizers (acetylators)
			- side effects:
				- causes reflex tachycardia
				- potential MI, so careful w/ CAD (use with beta-blocker)
				- headache (increased cerebral vasodilation)
				- palpitations (secondary to reflex tachycardia)
				- flushing (increased systemic vasodilation)
				- nausea
				- anorexia
				- lupus like syndrome (especially in slow acetylators)

		- minoxidil
			- mechanism: increases Na channel permeability (SM muscle hyperpolarization + relaxation)
			- PI: severe or refactory htx
			- short half life
			- side effects:
				- potential reflex tachycardia
				- potential decrease renal perfusion -> fluid retention
					- use diuretic to mitigate
				- hypertrichosis (rogaine)
				- pericardial effusion (rare)

		- fenoldopam
			- D1 agonist -> cAMP dependent arteriolar vasodilation
			- increases renal perfusion
				- increase natriuresis by renal tubular D1
			- 50% max effect at 15 mins, steady state in 30-60 mins, 10 min half life
			- side effects
				- headache
				- dizziness
				- tachycardia
				- increased intraocular pressure
					- avoid for pts w/ glaucoma


		- calcium channel blockers
			- prevents influx of Ca in cardiac and smooth muscles
				- L type (funny currents, pacemaking)
				- T-type (depolarization)
			- decreased calcium causes muscle relaxation (vasodilation + negative inotrope)
			- general side effects:
				- hypotx

			- types:
				- non-dyhydropyridines
					- verapamil
						- strong negative inotrope
						- strong AV node conduction suppression
						- side effects:
							- hypotension
							- bradycardia
							- AV block
							- constipation
					- diltiazem
						- medium negative inotrope
						- medium AV node conduction suppression
						- side effects
							- hypotension
							- peripheral edema
							- bradycardia

				- dihydropyridines
					- strong vasodilation
					- weak negative inotropic effect
					- side effects:
						- hypotension
						- headache
						- flushing
						- peripheral
						- edema
					- list:
						- amlodipine
						- felodipine
						- isradipine
						- nicardipine
						- nifedipine
						- nisoldipine


antiadrenergics:
	- beta blockers
		- side effects:
			- bronchospastic airway disease
			- heart block
			- untreated congestion / pulmonary edema
			- negative inotrope -> cardiogenic shock
			- can mask hypoglycemia
			- raise LDL, triglycerides
			- never treat sinus tachycardia with beta blockers

		- nonselective beta blockers:
			- carvedilol
			- labetaol
			- propranolo
			- nadolol
			- timolol
		- beta 1 selective blockers:
			- atenolol
			- betaxolol
			- bisoprolol
			- esmolol
			- metoprolol
			- nebivolol

	- central alpha-2 agonists
		- clonidine
		- alpha-methyldopa
		- guanabenz
		- guanfacine

	- peripheral alpha blocks
		- alpha 1 selective
			- prazosin
			- terazosin
			- doxazosin
		- non-selective (for pheochromocytoma)
			- phentolamine
			- phenoxybenzamine


antiarrhythmics:
	guide:
		- early repolarization time = ERP
		- AP duration = action potential duration

	- class I: Na+ channel blockers:
		- affect contractile myocytes
		- decreased slope of phase 0 + 4 depolarization
		- slow conduction velocity / inhibit depolarization

		- class IA: 
			- prolong repolarization
			- watch QT
			- caution in renal dysfunctio
			- uses: SVTs, AF, VT, less used
			- list:
				- quinidine: diarrhea, vagolytic, low platelets, torsades, drug irx
				- procainamide: lupis-like syndrome, agranulocytosis, torsades, variable metabolizers
				- disopyramide: anticholinergic, negative inotrope

		- class IB:
			- shortens repolarization
			- uses: best for fast VTs, little effect on atrial tissue
				- VTs
				- afterdepolarizations: does not increase QT
					- digoxin induced VT
					- torsades / long QT

			- caution: hepatic dysfunction
			- list:
				- lidocaine IV: neurologic, dizziness, seizures, sinus slowing
				- mexiletine PO: neurologic, dizziness, seizures, GI
				- phenytoin (rare): gingival hyperplasia

		- class IC:
			- prolong repolarization
			- most potent Na effect -> watch for widening QRS
			- uses: afib, refractory SVTs
			- side effects: paresthesias, diplopia, chest pain
			- caution: pro-arrhythmic
				- increased mortality in structural heart disease (post-MI)
				- can slow atrial flutter rates -> 1:1 AV conduction
			- list:
				- flecainide
				- propafenone

	- class II: β-blockers:
		- affects pacemaker cells
		- phase 4 slope decreased
		- prolonged AV node conduction / repolarization
		- slows sinus node and AV node
		- block effect of catecholamines

		- uses:
			- SVTs or VT (esp exercise or emotionally induced)
			- ventricular rate control in afib / aflutter
			- MI + CHF: mortality benefit
		- side effects:
			- bradycardia
			- hypotension
			- fatigue
			- dizziness
			- bronchospasm
			- vasospasm
		- list:
			- metoprolol
			- propranolol
			- esmolol
			- etc

	- class III: K+ channel blockers:
		- affects contractile myocytes
		- prolong phase 3 repolarization
			- prolong refractoriness / QT
		- uses: afib, VT
		- side effects:
			- long QT / torsades: worsened by hypo K/M
			- reverse-use dependence - sotalol: more effect at slower HR
			- renally excreted: sotalol + dofetilide
		- list:
			- amiodarone: decreases conduction velocity (phase 0) + automaticity (phase 4)
				- most effective for:
					- recurrent AF
					- VT/VF, particularly w/ cardiomyopathy
				- lots of side effects

			- sotalol: 
			- dofetilide
			- ibutilide IV
			- dronenarone

	- class IV: Ca++ channel blockers:
		- slow SA node (some) + slow AV node (more)
		- affects pacemaker cells
		- increased PR interval
		- blocks L-type Ca channels: slows phase 0 + 4
		- prolonged repolarization at AV node + refractoriness
		- uses: afib/aflutter, SVT
		- side effects:
			- bradycardia
			- CHF
			- hypotension
			- fatigue
			- constipation
			- gingival hyperplasia
			- edema

		- list:
			- diltiazem
			- verapamil

	- others:
		- digoxin:
			- increases vagal tone -> Na pumps
			- blocks Na-K ATPase -> increased intracellular Ca -> inotrope
			- uses: AF with RVR, esp. in CHF
			- side effects:
				- narrow window, esp w/ low K+
				- AV block
				- bradycardia
				- nausea + vomiting
				- yellow/green color change
				- SVT/VT w/ overdose

		- adenosine:
			- adenosine A1 receptor -> decreased AV node conduction
			- reduces automaticity
			- shortens atrial refractoriness -> can cause afib
			- use: reentrant SVT
			- side effects:
				- SA node slowing
				- AV block/systole
				- flushing, headache, chest pain
				- bronchospasm

		- ivabradine:
			- blocks funny current -> decreases HR
			- used w/ β-blockers for CHF w/ LVEF <= 35% and HR >= 70 bpm


diuretics:
	- loop diuretics:
		- inhibits: Na/K/2CL co-transporter in thick ascending loop of henle (~25%)
		- venodilation
		- increases RAAS
		- side effects:
			- volume depletion
			- hypokalemia
			- metabolic aklalosis
			- hypomagnesaemia
			- ototoxicity
		- list:
			- furosemide (lasix)
				- onset: 5 mins IV, 1 hr PO
				- duration: 2 hrs IV, 4-6 hrs PO
			- bumetanide (bumex) 
			- torsemide (demadex)
			- ethacrynic acid (only non-sulfa -> high ototoxicity)

	- thiazide diuretics:
		- inhibits NaCl co-transporter at distal tubule (~5%)
		- longer duration than loop
		- poor efficacy in renal dysfunction, except for metolazone
		- used as loop diurectic potentiator
		- side effects:
			- hypokalemia
			- metabolic aklalosis
			- hyponatremia
			- hyperuricemia
			- hyperglycemia
			- hypercalcemia
			- increased lipids
		- list:
			- chlorothiazide
			- hydrochlorothiazide
			- chlorthalidone
			- metolazone

	- K-sparing diuretics:
		- reduced K excretion at distal convoluted tubule + collective tubule
		- used w/ thiazide or loops for hypokalemia
		- side effects:
			- hyperkalemia
			- gynecomastia
			- breast tenderness
		- list:
			- spironolactone
			- eplerenone
			- triamterene (inhibit Na permeability at collecting duct)
			- amiloride (inhibit Na permeability at collecting duct)


antithrombotics:
	- antiplatelet
		- aspirin
			- irreversible thromboxane A2 inhibitor
				- higher doses inhibits prostacyclin (PGI2) as well
			- if plug already formed, ASA inhibited platelets can join

		- dipyridamole
			- decreases thromboxane A2 production
			- enhances aspirin effect

		- GP IIb/IIIa inhibitors
			- stop fibrinogen-induction
			- extremely potent (effectively zero platelet function)
			- half life 2-2.5 hours
			- used for restenosis prevention
			- list:
				- epitifibatide
				- tirofiban
				- abciximab
			- side effects:
				- thrombocytopenia

		- ADP receptor inhibitors
			- block P2Y12 receptor
			- uses:
				- unstable angina
				- NSTEMI
				- STEMI
				- CAD intervention
				- stroke
				- peripheral vascular disease
			- list:
				- clopidogrel (plavix)
				- prasugrel (effient)
				- ticagrelor (brilinta)
				- cangrelor (kengreal) (IV)
			- side effects:
				- bleeding
				- thrombotic thrombocytopenic purpura
				- neutropenia

	- anticoagulation
		- prevent clot propagation
		- prophylactic and treatment

		- heparins
			- activate antithrombin III
			- unfractionated:
				- old, cheap, effective treatment, some prophylactic
				- fully reversible
				- short half life
				- monitoring required (to ensure antithrombotic effect)
				- higher risk of complications
			- low molecular weight
				- subq 1-2x/day
				- no monitoring required (except for morbid, obsesity, cachexia, renal disease, pregnancy)
				- lower risk of de novo thrombocytopenia
				- effective treatment + effective high risk prophylactic
				- partially reversible
				- list:
					- enoxaparin (lovenox)
					- dalteparin (fragmin)


		- warfarin
			- inbibits vitamin K dependent caroxylase (inhibited during production)
			- monitor using PTT / INR
			- antidote is vitamin K
			- for non-valvular afib stroke prevention
			- only med for stroke prevention for
				- valvular afib
				- mechanical prosthetic valve

		- factor Xa inhibitors
			- not reversible
			- all problematic w/ renal dysfunction
			- fondaparinux (arixtra)
				- only inhibit Xa
				- daily
				- no thrombocytopenia
				- superior to LWMH
			- rivaroxaban (xarelto)
				- oral Xa inhibitor
				- for non-valvular afib stroke prevention, high risk venous TE, peripheral vascular disease
			- apixaban (eliquis)
				- oral Xa inhibitor
				- for non-valvular afib, venous TE, extended prophylaxis for TE
			- edoxaban (savaysa)
				- oral Xa inhibitor
				- for non-valvular afib, venous TE, extended prophylaxis for TE

		- direct thrombin inhibitors
			- block site of thrombin
			- inhibit clot-bound + free thrombin
			- more potent than heparin
			- argatroban
				- 30 min half life
				- problematic w/ liver disease
				- irreversible
				- approved for heparin-induced thrombocytopenia + thrombosis + acute coronary syndromes
			- bivalirudin (angiomax)
				- short acting
				- irreversible
				- for unstable angina + angioplasty (only in cath lab)

			- dabigatran (pradaxa)
				- oral thrombin inhibitor
				- 4 hour half life
				- no monitoring needed
				- for non-valvular afib stroke prevention
				- reverisble with idarucizumab (praxbind)
					- effect in seconds

	- thrombolytic therapy
		- for stroke / MI
		- streptokinase
			- binds to pasminogen + activates second plasminogen to plasmin
			- high incidence of allergic reactions
		- urokinase
			- activates plasminogen directly
		- tissue plasminogen activator (TPA)
			- activates plasminogen directly

lipid regulators:
